| P50 | author | Tomasz Misztal | Q56285614 |
| | Tomasz Rusak | Q57054571 |
| | Anna Bodzenta-Lukaszyk | Q68115841 |
| P2093 | author name string | M Tomasiak | |
| | J Branska-Januszewska | |
| | M M Tomasiak-Lozowska | |
| P2860 | cites work | Asthma and coagulation | Q34248543 |
| | Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis | Q35167926 |
| | Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity. | Q36461468 |
| | The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate | Q37232969 |
| | Airway factor XIII associates with type 2 inflammation and airway obstruction in asthmatic patients | Q37292431 |
| | Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study | Q39499768 |
| | Reduced clot retraction rate and altered platelet energy production in patients with asthma | Q39795377 |
| | Peroxynitrite may affect clot retraction in human blood through the inhibition of platelet mitochondrial energy production | Q45157583 |
| | Platelet function and fibrinolytic activity in patients with bronchial asthma | Q45242667 |
| | The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis. | Q45906428 |
| | Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth. | Q46725762 |
| | Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure. | Q48727418 |
| | Asthma is associated with enhanced thrombin formation and impaired fibrinolysis. | Q50682473 |
| | Prothrombotic state in patients with severe and prednisolone-dependent asthma. | Q51561430 |
| P433 | issue | 2 | |
| P304 | page(s) | 314-319 | |
| P577 | publication date | 2016-10-14 | |
| P1433 | published in | Allergy | Q2699825 |
| P1476 | title | Asthma is associated with reduced fibrinolytic activity, abnormal clot architecture, and decreased clot retraction rate | |
| P478 | volume | 72 | |